CARD14 mutations may predict response to antitumour necrosis factor-α therapy in psoriasis: a potential further step towards personalized medicine.
Level V
Where this comes from
- Record sourced from PubMed, PMID 27484270.
- Also identified by DOI 10.1111/bjd.14795 and PMC identifier 5961628.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Linked Article:</b> http://dx.doi.org/10.1111/bjd.14461.
Medical subject headings
- Precision Medicine
- Psoriasis